China Pharmaceutical Market Overview 2015

DUBLIN--(BUSINESS WIRE)--Research and Markets (.researchandmarkets.com/research/j892gq/the) has announced the addition of the "The Pharmaceutical Market: China" report to their offering. We remain bullish on China s pharmaceutical sector despite the slowdown in the economy and political reshuffle. Alesse (Levonorgestrel Bp + Ethinylestradiol Bp) without Rx We do not think the reshuffle will have any adverse changes or cause any reversals to healthcare reform given that the country has been rolling out various healthcare schemes and that a key person overseeing these healthcare reform plans is Vice Premier Li Keqiang, the man who may potentially take over from Premier Wen Jiabao in the reshuffle. Buy Zanaflex (Tizanidine) However, the business environment will potentially be threaten by cost- containment policies as the country will have to contain its ever-growing healthcare expenditure. Risk/Reward Rating China continues to rank fourth out of the 18 key markets in Q1 Asia Pacific Pharmaceutical Risk/Reward Ratings with an unchanged score of 62.5 Its high ranking on the table (just behind developed markets Japan, South Korea and Australia) is largely due to the strong growth potential of the pharmaceutical market that is underpinned by a large and increasingly affluent population and an increasing burden of non-communication diseases. Competitive Landscape The competitive landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales - for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors. Key Topics Covered: 1. About Viagra Pack-90 () with free prescription SWOT 2. About Flutiair with no prescription Political 3. About Inderal (Propranolol) with free Rx Economy 4. Buy Coral Calcium online Operational Risk 5. http://asthmareview.wordpress.com Industry Forecast 6. Pharmaceutical Market Forecast 7. Healthcare Market Forecast 8. Prescription Drug Market Forecast 9. Patented Drug Market Forecast 10. Generic Drug Market Forecast 11. OTC Medicine Market Forecast 12. Pharmaceutical Trade Forecast 13. Key Risks To The Forecast Scenario 14. Macroeconomic Forecasts 15. Economic Activity 16. Industry Risk Reward Index 17. Asia Pacific Risk/Reward Index 18. China Risk/Reward Index 19. Rewards 20. Risks 21. Market Overview 22. Industry Trends And Developments 23. Epidemiology 24. Healthcare Sector 25. Research And Development 26. Clinical Trials 27. Biotechnology Sector 28. Regulatory Development 29. Regulatory Regime 30. Intellectual Property Issues 31. Pricing Regime 32. Reimbursement Regime 33. Competitive Landscape 34. Pharmaceutical Wholesale 35. Recent Developments Companies Mentioned - AstraZeneca - Bayer - China Shijiazhuang Pharmaceutical Group - Eli Lilly - GlaxoSmithKline - Merck & Co - Merck KGaA - North China Pharmaceutical Corporation - Novartis - Pfizer - Roche - Sanofi - Shanghai Pharmaceutical - Sinopharm For more information visit .researchandmarkets.com/research/j892gq/the

AstraZeneca Purchases US Biologics Manufacturing Facility to Support Growing Pipeline

WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca today added to its biologics manufacturing capability in the US with the purchase of a high-tech biologics bulk manufacturing facility from Amgen Inc. About Zovirax (Acyclovir) with free prescription Over time, the LakeCentre facility, located in Boulder, Colorado will increase manufacturing and production capacity to support the company’s extensive portfolio of biologics medicines. AstraZeneca plans to start staffing the facility immediately to support refurbishment and infrastructure improvements. Azelex (Azelaic Acid) without Rx Once complete, the site is expected to be operational and licensed for commercial production by late 2017, providing for additional capacity within the company’s biologics operations. In the longer- term, this site could create up to 400 highly skilled jobs, subject to relevant approvals by the local authorities. Adalat (Nifedipine) without prescription The facility will eventually double the biologics manufacturing capacity in the US to meet the needs of the maturing AstraZeneca pipeline. Femara with free prescription Currently biologics make up 50 percent of the company’s pipeline with more than 120 ongoing programmes, including over 30 in clinical development. Pam Cheng, Executive Vice-President, Operations and Information Technology at AstraZeneca, said: “The addition of the Boulder facility will support the progression of biotech drug candidates across our main therapeutic areas as we continue to bring innovative new treatments to patients. About Man XXX () with no prescription This site will play an important role in our future commercial production and give AstraZeneca and MedImmune, our global biologics research and development arm, the flexibility and capacity to meet the needs of our rapidly growing biologics portfolio.” The new facility in Boulder adds to the expansion of AstraZeneca’s biologics manufacturing capabilities, following the planned biologics manufacturing investment in Sweden, announced in May, and the expansion in Frederick, Maryland, announced in November 2014. The financial details were not disclosed. Buy Cayenne online This investment does not impact AstraZeneca’s financial guidance for 2015. – ENDS – NOTES TO EDITORS About AstraZeneca AstraZeneca is a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection and neuroscience diseases. http://medical-reviews.blogspot.com AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. For more information please visit: .astrazeneca.com

Global Brain Metastasis Therapeutics Pipeline Report 2015 - 23 Companies & 33 Drug Profiles

. Buy Breast Health online Mobic (Meloxicam) DUBLIN--(BUSINESS WIRE)--Research and Markets (.researchandmarkets.com/research/58tc2h/brain_metastasis) has announced the addition of the "Brain Metastasis - Pipeline Review, H2 2015" report to their offering. This report provides comprehensive information on the therapeutic development for Brain metastasis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. http://future-pharmaceuticals.blogspot.com Etosid with free prescription Buy Vesicare (Solifenacin) with free prescription It also reviews key players involved in the therapeutic development for Brain metastasis and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. Buy Nolvadex (Tamoxifen) without prescription Buy Cialis Black (Tadalafil + L-Arginine + Giseng + Vitamin B6 + Folic Acid) with free prescription It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Companies Involved in Therapeutics Development AbbVie Inc. AngioChem Inc. BBB Therapeutics B.V. biOasis Technologies Inc. Bristol-Myers Squibb Company Diffusion Pharmaceuticals LLC e-Therapeutics Plc Exelixis, Inc. GlaxoSmithKline Plc Hutchison MediPharma Limited Komipharm International Co., Ltd. Nektar Therapeutics Nerviano Medical Sciences S.r.l. Novartis AG Oncothyreon Inc. Pfizer Inc. Philogen S.p.A. Phosplatin Therapeutics LLC Puma Biotechnology, Inc. Radius Health, Inc. Sanofi Spectrum Pharmaceuticals, Inc. Tocagen Inc. Drug Profiles dabrafenib mesylate + trametinib dimethyl sulfoxide 2B3-101 ANG-1005 ANG-4043 BT-2111 cabazitaxel cabozantinib s-malate ceritinib dacomitinib etirinotecan pegol ETS-2101 HMPL-813 ipilimumab irbinitinib KML-001 lucanthone hydrochloride MDNA-55 neratinib nimotuzumab NMSE-973 PB-357 PF-06463922 plinabulin PT-112 RAD-1901 radretumab RRX-001 TPI-287 transcrocetinate sodium Vaccine for Metastatic Brain Tumor veliparib vocimagene amiretrorepvec + flucytosine ER X-82 For more information visit .researchandmarkets.com/research/58tc2h/brain_metastasis